New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Avsola infliximab |
Amgen | Biosimilar to Remicade. |
|
Beovu brolucizumab |
Novartis | Intravitreal VEGF inhibitor for neovascular (wet) age-related macular degeneration. |
|
Cablivi caplacizumab |
Sanofi Genzyme | An injectable antithrombotic for acquired thrombotic thrombocytopenic purpura. |
|
Kanjinti trastuzumab |
Amgen | Biosimilar to Herceptin. |
|
Mayzent siponimod |
Novartis | An oral sphingosine 1-phosphate receptor modulator for multiple sclerosis. |
|
Nubeqa darolutamide |
Bayer | An oral antiandrogen for non-metastatic castration resistant prostate cancer. |
|
Osnuvo teriparatide |
Avir Pharma | A biosimilar to Forteo. |
|
Piqray alpelisib |
Novartis | Oral kinase inhibitor for advanced/metastatic breast cancer. |
|
Rozlytrek entrectinib |
Hoffmann-La Roche | A tyrosine kinase inhibitor for advanced extracranial solid tumours, including brain metastases. |
|
Vyndaqel tafamidis meglumine |
Pfizer | An oral transthyretin stabilizer for cardiomyopathy due to transthyretin-mediated amyloidosis. |
|
Xofluza baloxavir marboxil |
Hoffmann-La Roche | An oral antiviral for treating influenza. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Peyona caffeine citrate |
Chiesi (Spain) | CNS stimulant for primary apnea in premature newborns. |
|
Suvexx sumatriptan/naproxen |
Nuvo Pharm. | New oral triptan/NSAID combination for acute migraine. |
| Brand/Generic | Company | Description |
|---|